These four HCC patients were selected to represent the heterogeneity of primary HCCs in terms of age, tumor size, serum AFP level and immunohistochemical staining of Hep-1, a marker of differentiation (Table S1). This evidence concerns the gene AFP and hepatocellular carcinoma.